Your browser doesn't support javascript.
loading
Maintenance of Efficacy and Safety of Ustekinumab Through One Year in a Phase II Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Patients With Active Systemic Lupus Erythematosus.
van Vollenhoven, Ronald F; Hahn, Bevra H; Tsokos, George C; Lipsky, Peter; Fei, Kaiyin; Gordon, Robert M; Gregan, Irene; Lo, Kim Hung; Chevrier, Marc; Rose, Shawn.
Afiliação
  • van Vollenhoven RF; University of Amsterdam, Amsterdam, The Netherlands.
  • Hahn BH; University of California, Los Angeles.
  • Tsokos GC; Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts.
  • Lipsky P; AMPEL BioSolutions, LLC, Charlottesville, Virginia.
  • Fei K; Janssen Research & Development, LLC, Spring House, Pennsylvania.
  • Gordon RM; Janssen Research & Development, LLC, Spring House, Pennsylvania.
  • Gregan I; Janssen Research & Development, LLC, Spring House, Pennsylvania.
  • Lo KH; Janssen Research & Development, LLC, Spring House, Pennsylvania.
  • Chevrier M; Janssen Research & Development, LLC, Spring House, Pennsylvania.
  • Rose S; Janssen Research & Development, LLC, Spring House, Pennsylvania.
Arthritis Rheumatol ; 72(5): 761-768, 2020 05.
Article em En | MEDLINE | ID: mdl-31769212
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Ustekinumab / Lúpus Eritematoso Sistêmico Tipo de estudo: Clinical_trials / Observational_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Arthritis Rheumatol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Ustekinumab / Lúpus Eritematoso Sistêmico Tipo de estudo: Clinical_trials / Observational_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Arthritis Rheumatol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda